INS and diabetes mellitus: Of note, a 3-month treatment with empagliflozin was recently reported to restore the blood circulating quantities of this miRNA in frail older adults with heart failure and diabetes mellitus; the study also demonstrated that this effect was specific for the SGLT-2i, compared with treatment with insulin, or also metformin in the same patients [97].